The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping ...
Integra LifeSciences has recalled wound and burn treatments over issues linked to 14 serious injuries, the Food and Drug Administration said Thursday. The FDA published an early alert after Integra ...
Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.
The nonprofit said technologies like ChatGPT have suggested incorrect diagnoses, invented body parts and otherwise provided ...
Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...
AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.
Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...
CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...
The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff ...
Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the ...
Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...
Abbott’s latest CE mark for its TactiFlex Duo system was based on a clinical trial conducted in the European Union, United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results